Pages that link to "Q83395090"
Jump to navigation
Jump to search
The following pages link to Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant (Q83395090):
Displaying 5 items.
- Pharmacogenetic studies update in type 2 diabetes mellitus (Q26739350) (← links)
- KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment. (Q33771570) (← links)
- Personalized medicine in diabetes mellitus: current opportunities and future prospects (Q35779453) (← links)
- Pharmacogenetics and personalized treatment of type 2 diabetes (Q37508445) (← links)
- Changing the Treatment of Permanent Neonatal Diabetes Mellitus from Insulin to Glibenclamide in a 4-Month-Old Infant with KCNJ11 Activating Mutation (Q41883942) (← links)